New sepsis data indicates very good efficacy in Apta-1 treated primates
2018-11-14
Aptahem (publ) announce today that the extended exploratory sepsis study in primates has shown positive results. This increases the hope of being able to show good efficacy also in upcoming and more extensive confirmatory studies. After the company announced...
Read More